Ten Bio, founded in 2019 and headquartered in the United Kingdom, specializes in the biotechnology sector, with a focus on Health Care and Life Sciences. With their slogan, "Optimal human skin models for optimal results," they emphasize their dedication to delivering precise skin biology testing solutions. Their proprietary culture platform effectively restores physiological skin tension, establishing a realistic and functional testing environment for skin-related research.
By providing accurate data that mimics in vivo conditions, Ten Bio enables dermatology product developers to significantly reduce R&D costs and speed up their product development process. The company's innovative approach gives it a competitive edge in the sector, though they are yet to secure a disclosed round of external investment. With the increasing demand for reliable skincare testing methods in the market, Ten Bio presents a compelling proposition for prospective investors in the biotechnology arena.